Skip to main content
. 2020 Oct 21;36(4):739–748. doi: 10.1007/s10557-020-07098-3

Fig. 2.

Fig. 2

Pathophysiology of cardiopulmonary induced vasoplegia and existing therapies (AII, angiotensin II; AVP, arginine vasopressin; B12, hydroxocobalamin; iNOS, inducible nitric oxide synthase)